Healthcare -
Biotechnology - NASDAQ - US
$ 8.5847
8.67 %
$ 425 M
Market Cap
-1.71
P/E
RGNX - TOTAL CURRENT ASSETS
Total Current Assets RGNX - REGENXBIO Inc.
335 M
LAST VALUE
-19.65%
2 YEAR CAGR
-0.17%
5 YEAR CAGR
65.24%
10 YEAR CAGR